BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21863064)

  • 1. Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418.
    Wen Q; Yu G; Li YL; Yan LD; Gong ZH
    Acta Pharmacol Sin; 2011 Oct; 32(10):1215-24. PubMed ID: 21863064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.
    Healy JR; Bezawada P; Shim J; Jones JW; Kane MA; MacKerell AD; Coop A; Matsumoto RR
    ACS Chem Neurosci; 2013 Sep; 4(9):1256-66. PubMed ID: 23713721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor.
    Zhou P; Li Y; Yong Z; Chen M; Zhang Y; Su R; Gong Z
    Brain Res; 2020 Dec; 1748():147083. PubMed ID: 32871137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
    Li JX; Becker GL; Traynor JR; Gong ZH; France CP
    J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine.
    Yu G; Yue YJ; Cui MX; Gong ZH
    J Pharmacol Exp Ther; 2006 Jul; 318(1):282-7. PubMed ID: 16569757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TH-030418: a potent long-acting opioid analgesic with low dependence liability.
    Yu G; Yan LD; Li YL; Wen Q; Dong HJ; Gong ZH
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):125-31. PubMed ID: 21594658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.
    Huang P; Kehner GB; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2001 May; 297(2):688-95. PubMed ID: 11303059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.
    Khroyan TV; Polgar WE; Cami-Kobeci G; Husbands SM; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2011 Mar; 336(3):952-61. PubMed ID: 21177476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
    Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
    Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Azuma T; Ichikawa D; Nambu H; Iguchi T; Iwasawa Y; Ohta H
    Eur J Pharmacol; 2000 Aug; 402(1-2):45-53. PubMed ID: 10940356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.
    Khroyan TV; Wu J; Polgar WE; Cami-Kobeci G; Fotaki N; Husbands SM; Toll L
    Br J Pharmacol; 2015 Jan; 172(2):668-80. PubMed ID: 24903063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of mixed NOP and mu-opioid receptor ligands.
    Spagnolo B; Calo G; Polgar WE; Jiang F; Olsen CM; Berzetei-Gurske I; Khroyan TV; Husbands SM; Lewis JW; Toll L; Zaveri NT
    Br J Pharmacol; 2008 Feb; 153(3):609-19. PubMed ID: 18059322
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lattanzi R; Rief S; Schmidhammer H; Negri L; Spetea M
    Front Pharmacol; 2018; 9():1002. PubMed ID: 30233377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological activity of thebaine-derived mu-opioid receptor agonists.
    Shafiee A; Amanlou M; Farsam H; Dehpour AR; Mir-Ershadi F; Mani AR
    Pharm Acta Helv; 1999 Feb; 73(5):251-4. PubMed ID: 10085791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.